← FDA DRUG APPROVALS

FDA ANDA · ANDA203384

EPINASTINE HYDROCHLORIDE

Sponsor: CHARTWELL RX

APPLICATION
ANDA203384
TYPE
ANDA
ORIGINAL APPROVAL
2016-12-07
LATEST ACTION
2016-12-07
ROUTE
OPHTHALMIC
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued

Products

EPINASTINE HYDROCHLORIDEDiscontinued
EPINASTINE HYDROCHLORIDE 0.05% · SOLUTION/DROPS · OPHTHALMIC

Approval history

2016-12-07UNKNOWN · OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →